Xiidra vs Restasis: Effectiveness, Cost & Safety
Understanding Dry Eye and Prescription Treatment Options
Dry eye happens when you do not make enough tears or when tears evaporate too fast. This can result from aging, certain medications, medical conditions like arthritis or thyroid problems, or environmental factors. Over time, the surface of your eye becomes inflamed, which creates a cycle where inflammation makes dry eye worse.
Unlike temporary dryness from wind or screen time, chronic dry eye disease persists for months or years. The inflammation damages the cells that produce tears, so simply adding artificial tears may not be enough to break the cycle and restore comfort.
Many people with dry eye notice a gritty or sandy feeling in their eyes, burning, redness, or blurry vision that comes and goes. You might also experience excessive tearing, which seems strange but happens because your eyes try to compensate for dryness. Some patients find their eyes feel worse in the morning or after reading or computer work.
- Persistent burning or stinging that artificial tears do not fully relieve
- Difficulty wearing contact lenses comfortably
- Eye fatigue that interferes with daily activities
- Frequent fluctuations in vision clarity
- Significant light sensitivity, especially with pain
During your exam, we look at the surface of your eyes under magnification to check for inflammation and damage. We measure how much tears your eyes produce and how quickly they evaporate. Special dyes help us see areas where the cornea or conjunctiva have become irritated or injured.
We also ask about your symptoms, medications, and lifestyle to identify what might be contributing to your dry eye. This complete picture helps us decide whether prescription treatment is right for you and which medication may work best.
- Schirmer test to assess tear volume
- Tear breakup time to evaluate tear film stability
- Ocular surface staining with fluorescein or lissamine green
- Meibomian gland assessment or meibography
- Tear osmolarity and MMP-9 testing for inflammation
We may recommend Xiidra or Restasis when over-the-counter artificial tears and lifestyle changes do not provide lasting relief. Prescription drops become important if we see signs of inflammation or if your tear production is significantly reduced. These medications target the root cause rather than just masking symptoms.
If you have moderate to severe dry eye disease, starting a prescription treatment early can help prevent further damage to your eye surface and improve your quality of life. We will discuss your specific situation and treatment goals at your appointment.
How Xiidra and Restasis Work
Inflammation is the key driver of chronic dry eye disease. When your eyes are dry, immune cells release inflammatory signals that damage the glands and cells responsible for making healthy tears. This creates a vicious cycle where dry eyes become more inflamed and inflammation leads to even less tear production.
Both Xiidra and Restasis work by reducing this inflammation, but they do so through different pathways. By calming the immune response on your eye surface, these medications can help your eyes produce better quality tears and heal from previous damage.
Restasis contains cyclosporine, an immunosuppressant that decreases the activity of certain immune cells in your eyes. It works by blocking signals that trigger inflammation and reduce tear production. Over time, this allows the tear-producing glands to function better and make more natural tears.
- Suppresses T-cell activity that drives inflammation
- Helps restore normal tear production capacity
- Requires consistent use to maintain benefits
- Available in 0.05% concentration
Xiidra uses a different mechanism than Restasis. It contains lifitegrast, which blocks a specific protein interaction that immune cells use to communicate and cause inflammation. By interrupting this signal, Xiidra reduces both the signs and symptoms of dry eye disease.
Xiidra targets a different step in the inflammation pathway. Some patients who do not respond well to one medication may find success with the other because of these distinct mechanisms.
Both medications require patience because they work gradually to reduce inflammation and improve tear production. Most patients using Xiidra notice some symptom improvement within two weeks, though full benefits may take six to twelve weeks. With Restasis, it typically takes three to six months to see meaningful improvement, although some people notice changes sooner.
We will check your progress and adjust treatment if needed. It is important to use your drops exactly as prescribed during this time, even if you do not feel immediate relief. For patients starting cyclosporine, a short course of a low-risk steroid drop to bridge the first few weeks may improve comfort and speed early relief. We will advise if this is appropriate for you.
Comparing Effectiveness Between Xiidra and Restasis
Clinical trials for Xiidra have demonstrated significant improvements in both the symptoms and signs of dry eye disease. Studies showed that patients using Xiidra experienced better relief from eye discomfort and irritation compared to those using placebo drops. Xiidra also reduced visible signs of inflammation on the eye surface.
In these studies, a meaningful percentage of patients reported symptom improvement within the first two weeks of treatment. The medication continued to show benefits throughout the twelve-week study period, with many patients experiencing ongoing relief.
Restasis has been studied extensively since its approval and has shown effectiveness in increasing tear production in patients with chronic dry eye. Clinical trials found that Restasis improved tear production in a significant portion of patients compared to the vehicle alone. Many patients also experienced relief from symptoms like burning and grittiness.
The research shows that Restasis works best when used consistently over several months. Long-term studies have confirmed that patients who continue using Restasis maintain improved tear production and symptom control. Using Restasis consistently is important; stopping early can limit the chance to see full benefit.
Xiidra generally provides faster symptom relief than Restasis. Many patients using Xiidra notice some improvement in discomfort within two weeks, while Restasis typically requires at least several weeks to months before patients feel significant relief. This difference in speed may matter if you are looking for quicker symptom control.
However, faster initial relief does not necessarily mean one medication is more effective than the other in the long run. Both can provide substantial benefits when used as directed over time. We will choose the option that best matches your exam findings and goals, then reassess your response.
Restasis has demonstrated increased tear production in a subset of patients. Xiidra improves signs and symptoms of dry eye and tear film quality; increases in measured tear volume are less consistent across studies. Both agents help restore healthier tear function over time by reducing ocular surface inflammation.
- Restasis directly increases tear volume in many patients
- Xiidra improves tear film stability and reduces inflammatory markers
- Both medications help restore healthier tear function over time
Individual responses vary widely, and we cannot always predict which medication will work better for you. Some patients respond very well to Restasis, while others find Xiidra more effective. Factors like the severity of your dry eye, the specific causes, and your overall health may influence how you respond.
Our eye doctor will consider your particular symptoms, exam findings, and treatment goals when recommending one medication over the other. If the first choice does not provide adequate relief after a fair trial, we can discuss switching to the alternative.
Side Effects and Safety Considerations
The most common side effect of Xiidra is a temporary taste disturbance, which many patients describe as an unusual taste in the mouth shortly after instilling the drops. This happens because the drops can drain through your tear ducts into your nose and throat. Other common reactions include eye irritation, blurred vision, and a sensation of something in your eye. Punctal occlusion for 1 to 2 minutes after dosing reduces the chance of an altered taste.
- Altered taste sensation that usually fades quickly
- Mild burning or stinging upon instillation
- Temporary blurred vision
- Eye discomfort or redness
Many patients using Restasis experience burning or stinging when they first put the drops in their eyes. This sensation is usually temporary and often improves as you continue using the medication. Other common side effects include eye redness, watery eyes, and a feeling of something in the eye. Inverting the vial several times before use can help make the emulsion more comfortable.
The burning sensation is often reported with Restasis, but experiences vary. Storing the drops in the refrigerator before use may help reduce this discomfort for some people.
Serious side effects from Xiidra or Restasis are rare, but you should contact us immediately if you develop signs of an allergic reaction such as severe eye pain, significant swelling of the eyes or face, difficulty breathing, or a rash. Any sudden vision loss or severe eye pain warrants urgent evaluation.
If you notice increasing redness, discharge, or pain that worsens instead of improving after starting your medication, let us know right away. These could be signs of an eye infection or another problem that needs prompt attention.
- Severe light sensitivity with pain
- A white spot on the cornea
- Thick or worsening yellow or green discharge
- New halos around lights or sudden onset of many floaters
Tell our eye doctor if you have an active eye infection. We typically treat the infection first and pause or delay anti-inflammatory dry eye drops until your infection has cleared.
Tell our eye doctor if you are pregnant, breastfeeding, or planning to become pregnant, as safety data in these situations is limited.
- Active bacterial, viral, or fungal eye infections should be treated first before starting these drops
- Known allergy to any ingredient in the medication
- Autoimmune diseases often benefit from these medicines; we may coordinate with your other doctors when needed
- Pregnant or breastfeeding patients should discuss risks and benefits; safety data are limited. Use only if the expected benefit justifies potential risks
- Pediatric use has not been established
If you wear contact lenses, you should remove them before instilling Xiidra or Restasis and wait at least fifteen minutes before putting them back in. Do not instill either medication while wearing contact lenses. The medications contain ingredients that can interact with contact lens materials or be absorbed by the lenses. Many patients with chronic dry eye find they need to reduce or stop contact lens wear while their eyes heal.
We will discuss your contact lens use during your appointment and help you develop a strategy that allows your eyes to respond to treatment while meeting your vision needs. If you develop persistent lens intolerance, we may recommend a temporary break or a different lens material.
Cost, Insurance, and Practical Considerations
Both Xiidra and Restasis are brand-name medications and can be expensive without insurance coverage. The retail cost for a month supply of either medication typically ranges from several hundred dollars. Actual out-of-pocket costs depend on your insurance plan, deductible, and copay structure.
Because both medications are in a similar price range, cost alone may not be the deciding factor between them. We will help you explore coverage options and assistance programs to make your treatment more affordable. A 30-day supply may be dispensed as 60 single-use vials or as a multidose bottle for some cyclosporine products, which can affect the listed price and copay.
Many insurance plans cover Xiidra or Restasis, but most require prior authorization before approving the prescription. This means our office must submit documentation showing that you have chronic dry eye disease and may need to demonstrate that you tried other treatments first. The approval process can take several days to a few weeks.
Some insurance plans prefer one medication over the other or place them on different coverage tiers. Our staff can check your specific plan and help navigate the prior authorization process to get you the coverage you need.
As of 2025, generic cyclosporine products are available as alternatives to brand-name Restasis. These generic versions contain the same active ingredient at the same concentration and can significantly reduce your cost. Generic options for Xiidra are not yet available, though this may change in the future. Packaging and vehicle formulations can differ among cyclosporine products, which can affect comfort.
If cost is a major concern and you are prescribed cyclosporine, using a generic version can provide the same therapeutic benefits at a lower price. We will discuss whether a generic option is appropriate for your situation. If you switch between a brand and a generic and notice changes in comfort or effect, let us know so we can adjust your plan.
Both manufacturers offer patient assistance programs and savings cards that can reduce your out-of-pocket costs. These programs may provide free or discounted medication if you meet certain income requirements or help lower copays for insured patients. Eligibility requirements and benefits vary by program.
- Manufacturer copay cards that reduce costs for commercially insured patients
- Patient assistance programs for uninsured or underinsured individuals
- Pharmacy discount programs that may offer lower prices
- Our staff can help you apply for available programs
Manufacturer copay programs typically apply to commercial insurance; patients with government insurance usually are not eligible.
Both Xiidra and Restasis are dosed twice daily, approximately twelve hours apart. This means you instill one drop in each eye in the morning and one drop in each eye in the evening. Consistency matters for both medications, so establishing a routine helps you remember your doses.
Xiidra is supplied as preservative-free single-use vials. Cyclosporine products may be supplied as single-use vials or as a preservative-free multidose bottle, depending on the brand or generic. Follow the package directions for your specific product.
- If you use more than one eye medication, separate each drop by at least 5 to 10 minutes to avoid washout
- For Restasis single-use vials, invert the vial several times before use to make the emulsion uniform
- Use punctal occlusion after each dose. Gently press on the inner corner of your closed eyelids for 1 to 2 minutes to reduce the chance of a bad taste and to keep the drop on the eye
- Avoid touching the tip of the vial or bottle to your eye or skin
- Use each single-use vial for both eyes, then discard it
- Do not drive or operate machinery until any blurred vision clears
Choosing and Managing Your Dry Eye Treatment
We consider several factors when recommending Xiidra or Restasis, including the severity of your dry eye, your specific symptoms, your insurance coverage, and your treatment preferences. If you need faster symptom relief, we may lean toward Xiidra. If increasing tear production is the primary goal and you are willing to wait longer for results, Restasis might be a good choice.
Your past experience with eye medications, tolerance for side effects like burning or taste changes, and your ability to afford the medication also play important roles. We will discuss these factors together and make a personalized recommendation.
If you try one medication for an adequate period without sufficient improvement, we may recommend switching to the other. There is no significant risk in changing from Restasis to Xiidra or vice versa. We typically ask patients to use the first medication for at least three months before deciding it is not working, though we may switch sooner if you experience intolerable side effects.
When you switch medications, you can generally stop one and start the other without a washout period. We will give you specific instructions based on your individual response and timeline.
Xiidra or Restasis often work best as part of a comprehensive dry eye treatment plan. We may recommend continuing to use preservative-free artificial tears as needed for additional comfort. Other therapies like warm compresses, eyelid hygiene, omega-3 supplements, or in-office procedures can complement your prescription drops.
- Preservative-free artificial tears for breakthrough symptoms
- Warm compresses and lid massage for meibomian gland dysfunction
- Nutritional supplements such as omega-3s may help some patients with meibomian gland dysfunction; evidence is mixed
- Environmental modifications like humidifiers or protective eyewear
We will schedule a follow-up visit after you have been using your prescription drops for several weeks to months. At this appointment, we will reexamine your eyes to look for signs of improvement and ask about your symptoms. We measure tear production and check the health of your eye surface to see how well the medication is working.
These visits help us determine whether to continue your current treatment, adjust the plan, or add other therapies. Sharing honest feedback about your experience, including side effects and symptom changes, helps us provide the best care.
Reach out to our office if you develop any severe side effects, signs of infection, or worsening symptoms after starting your medication. You should also contact us if you are having trouble using the drops correctly, if cost is preventing you from filling your prescription, or if you have questions about your treatment plan.
Let us know if you experience persistent pain, vision changes, or eye redness that does not improve. We are here to support you throughout your treatment and can make adjustments to help you achieve the best possible outcome.
Frequently Asked Questions
Using both at the same time is not routinely recommended because evidence for added benefit is limited. In select refractory cases, your doctor may consider combination therapy off label with close follow-up. If more than one prescription drop is used, separate doses by at least 5 to 10 minutes.
Most patients need to use Xiidra or Restasis long term to maintain the benefits. Chronic dry eye disease is an ongoing condition, and stopping the medication often allows inflammation to return. Some patients may eventually reduce their dosing frequency or take breaks under our supervision, but this depends on how well your eyes respond and whether your symptoms stay controlled with other measures.
For many people, dry eye symptoms will gradually return after stopping Xiidra or Restasis because the underlying inflammation comes back. The timeframe varies, with some patients noticing symptoms within weeks and others remaining comfortable for months. We can help you decide when it might be appropriate to try reducing or stopping your medication based on how stable your condition has become.
If you do not respond adequately to either Xiidra or Restasis, or you cannot tolerate them, we have other options. We will work with you to find an approach that provides relief.
- Cyclosporine 0.09% (Cequa) or cyclosporine 0.1% (Vevye) for patients who need an alternative cyclosporine formulation
- Loteprednol 0.25% (Eysuvis) for short-term flares, typically up to 2 weeks
- Varenicline nasal spray (Tyrvaya) to increase natural tear production
- Perfluorohexyloctane (Miebo) for evaporative dry eye due to meibomian gland dysfunction
- Thermal pulsation or meibomian gland expression procedures for blocked oil glands
- Scleral lenses for severe ocular surface disease
- Autologous serum tears or platelet-rich plasma tears in advanced cases
Yes, you can and often should continue using preservative-free artificial tears as needed while taking prescription drops. The prescription medication addresses inflammation and improves tear production over time, while artificial tears provide immediate lubrication and comfort. Wait at least fifteen minutes after using your prescription drop before instilling artificial tears to avoid washing out the medication.
Getting Help for Xiidra vs Restasis: Effectiveness, Cost & Safety
Our eye doctor can evaluate your dry eye condition and help you determine whether Xiidra or Restasis is the right choice for your specific needs. We will work with you to address insurance coverage, manage side effects, and monitor your progress to ensure you achieve the best possible relief. Schedule an appointment to discuss your symptoms and explore prescription treatment options that can improve your eye comfort and health.